Immunomet Therapeutics, Inc. funding

Immunomet Therapeutics, Inc., a biotechnology company based in Houston, TX, filed a Form D with the SEC on February 5, 2026 and reported $842K raised of a $10M offering.

Amount raised$842K

Offering size$10M

Filed with the SECFebruary 5, 2026

First saleJanuary 21, 2026

IndustryBiotechnology

SecuritiesEquity, Options or warrants

LocationHouston, TX

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far4

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 5

Other health care rounds in Texas

OncoNano Medicine, Inc.$10.1M · Oct 8Biotechnology Solaris Endovascular Inc.$5M · Oct 1Biotechnology Transformer TX Holdings, LLC$4.1M · Nov 9Hospitals and Physicians Teos Health, LLC$3.1M · Oct 30Other Health Care Cerenome, Inc.$3M · Sep 18Other Health Care FibroBiologics, Inc.$1.2M · Oct 13Pharmaceuticals Pressio, Inc.$544K · Oct 6Other Health Care Ictero Medical, Inc.$344K · Nov 5Other Health Care